Sparks | The State of Psychedelics: Microdosing, Wellness and Beyond
Psychedelics are a hot topic today, from Michael Pollan’s personal adventures and accounts with his guided psych tours, to reports of top Silicon tech execs microdosing, to the new clinical research which indicates psychedelic’s positive impact on a variety of medical conditions, such as PTSD, psychedelics are having a zeitgeist.
Similar to cannabis, attitudes and beliefs about psychedelics are changing as people are becoming exposed to the potential health and wellness benefits. Whether you are psychedelic-curious, a casual lifestyle consumer or a person delving into the potential medical benefits they afford, we’re learning there’s a lot that psychedelics can potentially teach us, and in the process rewinding some of our previous misconceptions and beliefs.
In this interactive discussion we will delve into Ayelet’s first person account on how LSD was transformative during her own personal health crisis, to Rick’s perspective on running MAPS, a science and research driven institution whose mission is to help people benefit from the careful uses of psychedelics. In so doing, we will discuss MAPS latest development: FDA Phase 3 research into MDMA-assisted psychotherapy for people suffering from severe, chronic, post-traumatic stress disorder (PTSD).
This session will be live streaming from the Battery Facebook page here
With Ayelet Waldman and Rick Doblin
Moderated by Pamela Hadfield
Ayelet Waldman is the author of A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life, plus many award winning novels and essay collection such as Bad Mother: A Chronicle of Maternal Crimes was. Ayelet was Federal public defender and an adjunct professor at the UC Berkeley law school where she developed and taught a course on the legal implications of the War on Drugs. WEBSITE
Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986. WEBSITE
Pamela Hadfield is co-founder of HelloMD, the largest online community of health and wellness cannabis consumers. After treating her debilitating migraines with cannabis successfully, Pamela launched HelloMD, initially as a Telehealth service designed to connect medical cannabis patients with doctors from the privacy of home. HelloMD has since expanded to include community, educational content and now cannabis marijuana sales within California and CBD sales across the United States. As a leading female executive and passionate spokesperson for one the fastest growing industries in the world, Pamela has been featured in Forbes, The New York Times, Elle, Rolling Stone, Huffington Post, ADR, Now This, Parade Magazine, CBS Sunday Morning, Harper’s Bazaar, LA Weekly and Tech Crunch, among others. WEBSITE